Thus, we next sought to determine the extent to which the gene signatures we observe in iPSC-neurons from MAPT mutations are relevant to gene expression changes occurring in human brains with tauopathy and the extent to which these gene signatures are occurring across neurodegenerative diseases (Supplementary Table S12). The gene discussed is MAPT; the disease is neurodegenerative disease.